Clinical trials
Stroke (in Patients With Atrial Fibrillation) clinical trials
Below are recruiting stroke (in patients with atrial fibrillation) clinical trials, each written for real people, not researchers. We’re tracking 160 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07181590Recruiting
Balloon-based ablation for atrial fibrillation: post-approval study
This trial tests a balloon catheter that uses pulsed field energy to treat atrial fibrillation (AF) in people who have tried medication without success. It aims to see how well it works in real-world use.
LinzAges 18 years+ - NCT07253974Recruiting
Atrial Fibrillation Stroke Recovery Study
This study follows people who had a stroke linked to atrial fibrillation (an irregular heartbeat) and are in a rehabilitation program. Researchers want to see how recovery goes and what helps patients improve.
BarcelonaAges 18–99 - NCT07298473Recruiting
Redo ablation for recurrent atrial fibrillation with Sphere-9 catheter
This trial tests a new catheter and system for people who have had one previous ablation for atrial fibrillation but still have symptoms. It aims to see if a repeat procedure can safely and effectively treat recurrent episodes.
Birmingham, AlabamaAges 18 years+ - NCT07360899Recruiting
Closing the left atrial appendage during heart surgery to prevent stroke
This trial tests if closing the left atrial appendage with a special stitch during planned heart surgery can help prevent strokes in people with atrial fibrillation. If you already need heart surgery, this extra step may reduce your future stroke risk.
Kamenitz, VojvodinaAges 18 years+ - NCT02932007RecruitingPhase 2
Chloroquine to treat ongoing atrial fibrillation symptoms
This trial tests whether chloroquine can reduce symptoms in people with persistent atrial fibrillation (AF), an irregular heartbeat that lasts longer than a week. It will also closely monitor heart rhythm and safety, since the medicine can affect the heart and other organs.
Tampa, FloridaAges 18 years+ - NCT06315192Recruiting
Stroke alarm app trial for faster care
This trial tests a smartphone app called Stroke Alarm to see if it helps people who have had a recent stroke, mini-stroke, or have untreated atrial fibrillation get faster care. You may be eligible if you are 50 or older, have a smartphone, and had a relevant event in the last 2 weeks.
GothenburgAges 18 years+ - NCT07407790Recruiting
Smartphone heart check after stroke
This study tests whether using a smartphone app to check your heart rhythm after a stroke can find hidden atrial fibrillation (an irregular heartbeat). If you had a recent stroke or TIA and are not already on blood thinners, you may be able to help doctors detect and prevent future strokes.
KristiansandAges 18 years+ - NCT07441382Recruiting
Comparing treatments for frail older adults with atrial fibrillation
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
Guangzhou, GuangdongAges 75 years+ - NCT07444372Recruiting
CPAP for Sleep Apnea After Atrial Fibrillation Ablation
This trial tests whether starting CPAP therapy (a breathing mask used during sleep) after a heart procedure called atrial fibrillation ablation can help people with both sleep apnea and atrial fibrillation. It might lower the chance of the heart rhythm problem coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT07575867Recruiting
Reduced Blood Thinner Strategy After Heart Device Closure
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
MoscowAges 18 years+ - NCT07601763Recruiting
Pulsed Field Ablation for Atrial Fibrillation Treatment
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07159399Enrolling by invitation
Pharmacist-led education to help patients take blood thinners
This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.
TaipeiAges 18 years+ - NCT05997914Enrolling by invitation
Storytelling to reduce stroke risk in African Americans with atrial fibrillation
This study tests whether a storytelling program can help African American patients with atrial fibrillation start taking blood thinners as recommended by their doctor. The goal is to reduce stroke risk and improve health outcomes.
Jacksonville, FloridaAges 18 years+ - NCT05029115Enrolling by invitation
SGLT2 pill study for atrial fibrillation with type 2 diabetes
This trial tests whether an SGLT2 inhibitor pill can help people who have atrial fibrillation (an irregular heartbeat) and type 2 diabetes. You may be eligible if you’re in the right age range, on diabetes pills only, and meet specific heart and lab criteria.
Yangcheon, SeoulAges 20–80 - NCT04148625Enrolling by invitation
Sub-xiphoid hybrid maze for persistent atrial fibrillation after failed ablation
This trial studies a hybrid heart procedure to treat persistent atrial fibrillation in people whose previous catheter ablation did not work. It aims to improve heart rhythm and reduce ongoing symptoms by using a planned combination of techniques and careful follow-up.
Ages 18–80 - NCT06510556Recruiting
Testing a new mapping and ablation system for AFib
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
BrusselsAges 18 years+ - NCT07118488Recruiting
New ablation approach for persistent atrial fibrillation with heart issues
This study tests a new way to treat long-lasting atrial fibrillation using focused energy (pulse field ablation) guided by special heart mapping. It may help people who have not improved with medications or have other heart problems like heart failure.
Madrid, MadridAges 18–80 - NCT07347691Recruiting
AI predicts atrial fibrillation after stroke of unknown cause
This trial uses an artificial intelligence (AI) program to see if it can predict which patients who had a stroke from an unknown cause might develop atrial fibrillation (an irregular heart rhythm). If you have a small heart monitor already implanted, the AI will analyze your ECGs to find early signs of AFib, which could help prevent future strokes.
AnsanAges 30 years+ - NCT05341986Enrolling by invitation
ED tool to help prevent stroke in atrial fibrillation
This study tests an electronic decision-support tool used in the emergency department (ED) to help clinicians choose the safest way to prevent stroke when atrial fibrillation is newly found. It may help by improving how quickly and consistently stroke-prevention treatment is considered.
Portland, OregonAges 18 years+ - NCT07295769Recruiting
Detecting hidden atrial fibrillation after stroke of unknown cause
This study uses a small patch (M.E.M.O. Patch) to continuously monitor your heart rhythm for hidden atrial fibrillation, a treatable cause of stroke. The goal is to see if the patch can find irregular heartbeats that standard tests might miss.
Seoul, Songpa-guAges 19 years+ - NCT07713537Recruiting
Stroke risk score for AF patients on blood thinners
This study is testing a new scoring system to predict stroke risk in people with atrial fibrillation who are taking DOAC blood thinners. The goal is to help doctors personalize treatment and prevent blood clots.
Barcelona, BarcelonaAges Any age - NCT05610215Recruiting
Hybrid or catheter ablation for atrial fibrillation in hypertrophic heart
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
BeijingAges 18 years+ - NCT06499857RecruitingPhase 3
Semaglutide for atrial fibrillation and weight loss
This study tests whether a weekly injection of semaglutide (the same drug in Wegovy and Ozempic) can help people with atrial fibrillation lose weight and improve their heart condition. It's for people with AF who also have obesity, and may or may not plan to have a heart procedure called catheter ablation.
Phoenix, ArizonaAges 18–75 - NCT06589700Recruiting
Atrial Fibrillation and Stroke Risk Study
This study looks at the link between the type of atrial fibrillation (an irregular heartbeat that comes and goes) and the risk of having another stroke. It involves people who have had a recent ischemic stroke and have a certain type of AF.
London, OntarioAges 18 years+
Hear when a new Stroke (in Patients With Atrial Fibrillation) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stroke (in patients with atrial fibrillation)?
- Yes. Clin2 currently lists 160 recruiting stroke (in patients with atrial fibrillation) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stroke (in patients with atrial fibrillation) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stroke (in patients with atrial fibrillation) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.